1. Home
  2. CRBU vs JLS Comparison

CRBU vs JLS Comparison

Compare CRBU & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • JLS
  • Stock Information
  • Founded
  • CRBU 2011
  • JLS 2009
  • Country
  • CRBU United States
  • JLS United States
  • Employees
  • CRBU N/A
  • JLS N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • JLS Investment Managers
  • Sector
  • CRBU Health Care
  • JLS Finance
  • Exchange
  • CRBU Nasdaq
  • JLS Nasdaq
  • Market Cap
  • CRBU 93.0M
  • JLS 97.1M
  • IPO Year
  • CRBU 2021
  • JLS N/A
  • Fundamental
  • Price
  • CRBU $1.06
  • JLS $18.16
  • Analyst Decision
  • CRBU Strong Buy
  • JLS
  • Analyst Count
  • CRBU 4
  • JLS 0
  • Target Price
  • CRBU $8.50
  • JLS N/A
  • AVG Volume (30 Days)
  • CRBU 943.1K
  • JLS 26.6K
  • Earning Date
  • CRBU 05-08-2025
  • JLS 01-01-0001
  • Dividend Yield
  • CRBU N/A
  • JLS 9.33%
  • EPS Growth
  • CRBU N/A
  • JLS N/A
  • EPS
  • CRBU N/A
  • JLS N/A
  • Revenue
  • CRBU $9,918,000.00
  • JLS N/A
  • Revenue This Year
  • CRBU N/A
  • JLS N/A
  • Revenue Next Year
  • CRBU $161.81
  • JLS N/A
  • P/E Ratio
  • CRBU N/A
  • JLS N/A
  • Revenue Growth
  • CRBU N/A
  • JLS N/A
  • 52 Week Low
  • CRBU $0.66
  • JLS $15.48
  • 52 Week High
  • CRBU $3.00
  • JLS $17.97
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 56.92
  • JLS 52.98
  • Support Level
  • CRBU $0.98
  • JLS $17.88
  • Resistance Level
  • CRBU $1.21
  • JLS $18.23
  • Average True Range (ATR)
  • CRBU 0.10
  • JLS 0.18
  • MACD
  • CRBU 0.02
  • JLS 0.01
  • Stochastic Oscillator
  • CRBU 65.99
  • JLS 46.67

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.

Share on Social Networks: